KLHL6 Is Preferentially Expressed in Germinal Center–Derived B-Cell Lymphomas

Objectives KLHL6 is a recently described BTB-Kelch protein with selective expression in lymphoid tissues and is most strongly expressed in germinal center B cells. Methods Using gene expression profiling as well as immunohistochemistry with an anti-KLHL6 monoclonal antibody, we have characterized the expression of this molecule in normal and neoplastic tissues. Protein expression was evaluated in 1,058 hematopoietic neoplasms. Results Consistent with its discovery as a germinal center marker, KLHL6 was positive mainly in B-cell neoplasms of germinal center derivation, including 95% of follicular lymphomas (106/112). B-cell lymphomas of non-germinal center derivation were generally negative (0/33 chronic lymphocytic leukemias/small lymphocytic lymphomas, 3/49 marginal zone lymphomas, and 2/66 mantle cell lymphomas). Conclusions In addition to other germinal center markers, including BCL6, CD10, HGAL, and LMO2, KLHL6 immunohistochemistry may prove a useful adjunct in the diagnosis and future classification of B-cell lymphomas.

[1]  Jung-ah Kim,et al.  Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing , 2016, PloS one.

[2]  O. Sarig,et al.  Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of keratin 14 and human skin fragility , 2016, Nature Genetics.

[3]  V. Jobanputra,et al.  The genetic landscape of dural marginal zone lymphomas , 2016, Oncotarget.

[4]  R. Advani,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[5]  Chunaram Choudhary,et al.  Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation , 2015, Molecular systems biology.

[6]  Tom C Freeman,et al.  An expression atlas of human primary cells: inference of gene function from coexpression networks , 2013, BMC Genomics.

[7]  K. Dybkær,et al.  Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study , 2012, Leukemia.

[8]  Ugur Sahin,et al.  RNA-Seq Atlas - a reference database for gene expression profiling in normal tissue by next-generation sequencing , 2012, Bioinform..

[9]  D. Neuberg,et al.  Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. , 2012, Cancer discovery.

[10]  T. Chiba,et al.  Ubiquitin Ligase Activity of Cul3-KLHL7 Protein Is Attenuated by Autosomal Dominant Retinitis Pigmentosa Causative Mutation* , 2011, The Journal of Biological Chemistry.

[11]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[12]  A. Rosenwald,et al.  Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. , 2011, Blood.

[13]  D. Fanoni,et al.  New monoclonal antibodies against B-cell antigens: possible new strategies for diagnosis of primary cutaneous B-cell lymphomas. , 2011, Immunology letters.

[14]  R. Gascoyne,et al.  A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays. , 2010, The Journal of molecular diagnostics : JMD.

[15]  Juan F. García,et al.  Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype , 2010, Haematologica.

[16]  Kai Fu,et al.  A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy , 2009, Clinical Cancer Research.

[17]  Juan F. García,et al.  Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers , 2009, Modern Pathology.

[18]  L. Staudt,et al.  Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.

[19]  Martin-Leo Hansmann,et al.  Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis , 2008, The Journal of experimental medicine.

[20]  A Rosenwald,et al.  Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) , 2007, Journal of Clinical Pathology.

[21]  G. Sumara,et al.  A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells. , 2007, Developmental cell.

[22]  E. Schuuring,et al.  Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[24]  Claudia Waskow,et al.  The BTB-kelch Protein KLHL6 Is Involved in B-Lymphocyte Antigen Receptor Signaling and Germinal Center Formation , 2005, Molecular and Cellular Biology.

[25]  R. Rosenquist,et al.  Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis , 2005, Modern Pathology.

[26]  Wei Yan,et al.  Haploinsufficiency of kelch-like protein homolog 10 causes infertility in male mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.

[28]  J. D. Engel,et al.  Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation , 2003, Nature Genetics.

[29]  Adrian Wiestner,et al.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Weill,et al.  Specific over-expression of deltex and a new Kelch-like protein in human germinal center B cells. , 2003, Molecular immunology.

[31]  Yasodha Natkunam,et al.  Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry , 2001, Modern Pathology.

[32]  M. Koenig,et al.  The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy , 2000, Nature Genetics.

[33]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[34]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Pileri,et al.  Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. , 1997, The New England journal of medicine.

[36]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells , 1996, The Journal of experimental medicine.